YOU REWARD ME, will you get coupons and earn cash when you take surveys, dine and shop with our partners?
SANTIAGO: Johnson
Josue Bacaltchuk, Vice President of Medical Affairs for Latin America at Janssen, Belgian Unit of J
“We expect the majority in Brazil because it is the largest country and also the most affected by the pandemic, so we expect many other people to volunteer, but we also expect the best numbers in Colombia and Argentina.” Bacaltchuk said.
“The company’s goal is to prioritize countries that make a contribution to vaccine progression and involve patients in trials, yes,” he added in an interview with Reuters on Thursday.
J vaccine
The drug manufacturer is conducting tests in the United States and Belgium, and added Chile, Argentina and Peru to a list of Latin American countries where it plans to conduct Phase III trials with Brazil, Colombia and Mexico.
Your international trials will come with 60, 000 volunteers.
All Latin American countries have the highest number of infections, which makes them exciting verification sites for vaccine developers, as it is for downloading reliable verification effects in spaces with the highest rates of active transmission and infection.
Bacaltchuk said the resolution to disseminate the trials so widely boosted in component through the challenge of securing a sufficient number of volunteers in a populated domain through other pharmaceutical corporations that test their own prototypes.
“I think it is a prospective threat and that is why we went to a series of higher centers than the other corporations to cover geographic spaces that are not covered by the other studies,” he said. declared.
He the reaction of the volunteers of the region has been “quite positive” and hopes that it will continue.
“This has an effect on everyone and will continue to have an effect even after the end, the consequences will continue, so we will have to review it to prevent it as soon as possible,” he said.